Additional Diligence Clause Samples

Additional Diligence. The Purchaser shall, in its sole discretion, be satisfied with the results of its investigation with respect to the Invoiceable Global Imaging Costs, the New Warehoused Equipment, the Seller's Unamortized Liabilities, and the Highway Service Ventures, Inc. and Hardees Food Mart Re-Imaging amounts.
View SourceView Similar (2)
Additional Diligence. Client shall provide Company with all due diligence materials and information reasonably requested by Company about an Offering, including, without limitation, financial statements, technical reports and other information concerning Client’s business, operations, assets, liabilities, financial condition and prospects. Client shall make available officers of Client with responsibility for financial affairs and business operations to answer inquiries from Company, Subscribers, and Prospective Subscribers. Client shall provide the materials specified in Sections 4(b)(i) and 4(b)(ii) via transmission methods Company specifies.
View Source
Additional Diligence. Seller shall have provided Buyer with any reasonably requested information as provided in Section 13.7.
View Source
Additional Diligence. Odisei shall promptly provide to 8x8 and its legal counsel additional diligence materials reasonably requested by May 19, 1999, by 8x8 and its counsel.
View Source
Additional Diligence. The items marked with an asterisk on the DC Contributors Disclosure Schedule and including item 56 of Section 3.09 thereof shall be deemed not set forth therein. The Investor agrees to review such matters within 21 days following the date hereof at which time such matters shall be deemed disclosed in the DC Contributors Disclosure Schedule as of the date hereof except for (a) in the case of any such items that relate to representations and warranties any matter reasonably determined by the Investor to have a materially negative impact on the Company and its Subsidiaries, taken as a whole, and (b) in the case of any such items that relate to covenants, any item as to which the Investor notifies the DC Contributors (in which case the parties shall endeavor to discuss such item in good faith for a period of 30 additional days, at the end of which time, such item shall be deemed disclosed).
View Source

Related to Additional Diligence

  • Commercial Diligence Pfizer will use Commercially Reasonable Efforts to Commercialize a given Agreement Product in each Major Market Country in the Field in the Territory where Pfizer or its Affiliates have received Regulatory Approval for such Agreement Product. Pfizer will have no other diligence obligations with respect to the Commercialization of Agreement Products under this Agreement.

  • ACCESS AND COOPERATION; DUE DILIGENCE (i) Between the date of this Agreement and the Closing Date, the COMPANY will afford to the officers and authorized representatives of URSI and the Founding Companies other than the COMPANY access to all of the COMPANY's (including the COMPANY's Subsidiaries) key employees, sites, properties, books and records and will furnish URSI with such additional financial and operating data and other information as to the business and properties of the COMPANY (including the COMPANY's Subsidiaries) as URSI or the Founding Companies other than the COMPANY may from time to time reasonably request. The COMPANY will cooperate with URSI and the Founding Companies other than the COMPANY, its representatives, auditors and counsel in the preparation of any documents or other material which may be required in connection with any documents or materials required by this Agreement. URSI, the STOCKHOLDERS and the COMPANY will treat all information obtained in connection with the negotiation and performance of this Agreement or the due diligence investigations conducted with respect to the Founding Companies other than the COMPANY as confidential in accordance with the provisions of Section 14 hereof. In addition, URSI will cause each of the Founding Companies other than the COMPANY to enter into a provision similar to this Section 7.1 requiring each such Founding Company to keep confidential any information obtained by such Founding Company. (ii) Between the date of this Agreement and the Closing Date, URSI will afford to the officers and authorized representatives of the COMPANY access to all of URSI's sites, properties, books and records and will furnish the COMPANY with such additional financial and operating data and other information as to the business and properties of URSI as the COMPANY may from time to time reasonably request. URSI will cooperate with the COMPANY, its representatives, engineers, auditors and counsel in the preparation of any documents or other material which may be required in connection with any documents or materials required by this Agreement. The COMPANY will cause all information obtained in connection with the negotiation and performance of this Agreement to be treated as confidential in accordance with the provisions of Section 14 hereof.

  • Diligent Completion The Company agrees to use its reasonable efforts to cause the completion of the Project as soon as practicable, but in any event on or prior to the end of the Investment Period.

  • Development Diligence Pfizer will use its Commercially Reasonable Efforts to Develop and seek Regulatory Approval for one Product in the Field in [***]. Pfizer will have no other diligence obligations with respect to the Development or Regulatory Approval of Products under this Agreement.

  • Due Diligence During the term of this Agreement, the Company will reasonably cooperate with any reasonable due diligence review conducted by the Agent in connection with the transactions contemplated hereby, including, without limitation, providing information and making available documents and senior corporate officers, during normal business hours and at the Company’s principal offices, as the Agent may reasonably request from time to time.